-
Mar. 2021
Leukocare and Malvern collaborate on stabilization and formulation development of COVID-19 vaccines
-
Feb. 2021
Leukocare appoints Professor Ulrike Protzer as member to the Scientific Advisory Board
-
Jan. 2021
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
-
Oct. 2020
Leukocare announces formation of Scientific Advisory Board
-
Jun. 2020
Europas Hotspot der Corona- Bekämpfung
-
Apr. 2020
ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine
-
Apr. 2020
Coronavirus (COVID-19) statement LEUKOCARE has implemented and executes a Business Continuity Plan (BCP) - We remain fully operational for our clients
-
Jan. 2020
LEUKOCARE to publish new data on stable liquid viral vector formulations
-
Nov. 2019
LEUKOCARE´s 7th Scientific Formulation Symposium
-
Nov. 2019
LEUKOCARE to participate at several European Conferences